NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹136 Cr | ₹83 Cr | ₹122 Cr | ₹231 Cr | ₹170 Cr |
What is the latest Total Debt ratio of NEULAND LABORATORIES ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹136 Cr |
| Mar2024 | ₹83 Cr |
| Mar2023 | ₹122 Cr |
| Mar2022 | ₹231 Cr |
| Mar2021 | ₹170 Cr |
How is Total Debt of NEULAND LABORATORIES Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹136 Cr | 64.85 | |
| Mar2024 | ₹83 Cr | -32.10 | |
| Mar2023 | ₹122 Cr | -47.39 | |
| Mar2022 | ₹231 Cr | 35.71 | |
| Mar2021 | ₹170 Cr | - | |
Compare Total Debt of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹24,203.1 Cr | 0.7% | 12.5% | 57.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,593.0 Cr | 2% | 6.7% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,737.0 Cr | 3.5% | 2.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,290.0 Cr | 4.6% | 9.9% | 41.5% | Stock Analytics | |
| CIPLA | ₹117,327.0 Cr | -0.3% | 3.7% | -2.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,994.0 Cr | 1.1% | 5.9% | 6.6% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 0.7% |
12.5% |
57.1% |
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses